F-18 FAPI PET/CT upstages more newly-diagnosed breast cancers
AuntMinnie
SEPTEMBER 6, 2024
F-18 fibroblast activation protein inhibitor (FAPI) PET/CT leads to significant upstaging in newly diagnosed breast cancer, according to research published September 5 in Academic Radiology. The team put F-18 FAPI PET/CT to the test, comparing results to those of F-18 FDG PET/CT in systemic staging of newly diagnosed breast cancer.
Let's personalize your content